10 July 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the EU Pharmaceutical Strategy Roadmap

BEAM welcome the European Commission's ambition to support innovation in its upcoming Pharmaceutical Strategy. In our latest paper , we…

27 August 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the AMR Action Fund

The COVID-19 pandemic has stressed how drug and vaccine development requires time and resources. Whilst we welcome the launch of…

28 August 2020 - BEAM Alliance

BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics

18 November 2020 - Event

XIV European Patients’ Rights Day 2020 – Public and private sector challenges to address the “the Silent Tsunami”

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

17 November 2020 - Event

Fixing the antibiotic innovation pipeline; Online discussion hosted by the MEP Interest Group on AMR

The current antibiotic innovation pipeline is broken. The last antibiotic class that was successfully introduced as a treatment was discovered…

19 November 2020 - Event

XIV European Patients’ Rights Day 2020 – Towards an AMR citizens’ alliance

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

BEAM News
Member News
Events

Latest news of BEAM Alliance

22 January 2021 - BEAM Alliance

BEAM Alliance Joined The One Health Good Practices For The Successful Management Of Antimicrobial Resistance

The BEAM Alliance decided to join the Call To Action of the AMR Stakeholder Network, supported by the European Public…

18 November 2020 - BEAM Alliance

2020 Antimicrobial Resistance campaign: How to change the fight against AMR?

The BEAM Alliance recently worked with Global Cause on the 2020 Antimicrobial Resistance campaign.

09 November 2020 - BEAM Alliance

Antibiorésistance : Anticiper une nouvelle crise sanitaire

Florence Séjourné, présidente de BEAM Alliance : « Il faut anticiper les investissements en R&D dès maintenant pour avoir un…

28 August 2020 - BEAM Alliance

BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics

27 August 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the AMR Action Fund

The COVID-19 pandemic has stressed how drug and vaccine development requires time and resources. Whilst we welcome the launch of…

10 July 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the EU Pharmaceutical Strategy Roadmap

BEAM welcome the European Commission's ambition to support innovation in its upcoming Pharmaceutical Strategy. In our latest paper , we…

page 1/4

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

24 February 2021 - BioVersys AG

BioVersys, TASK and GSK receive 2.7 million Euro from EDCTP for Phase 2a Clinical Trial

BioVersys and consortium partners TASK Foundation and GSK have been awarded 2.7 million Euro from European and Developing Countries Trial…

23 February 2021 - Nabriva Therapeutics GmbH

Nabriva: Study Demonstrates Macrolide-Resistance in S. pneumoniae in the United States Exceeds 25 Percent Threshold Set in Current Community-Acquired Bacterial Pneumonia (CABP) Treatment Guidelines

XENLETA is a first-in-class systemic pleuromutilin antibiotic for the intravenous (IV) and oral treatment of CABP in adults. XENLETA offers…

03 February 2021 - Da Volterra

Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate its Phase 3 Clinical Trial Evaluating the Microbiome Protector DAV132 in Patients with Hematologic Malignancies

DAV132 is a unique and first-in-class product designed to inactivate antibiotics circulating in the colon and disrupting the gut microbiome.…

27 January 2021 - tranScrip

tranScrip announces landmark investment from Palatine Private Equity

tranScrip is delighted to announce a significant minority investment from Palatine Private Equity Impact Fund, which complements the existing investment…

25 January 2021 - Omnix Medical

Omnix Medical Wins €10.8M In EIC Accelerator Funding

Omnix Medical was founded on 2015 to address the urgent need for new life-saving antibiotics. Omnix´ proprietary technology eliminates bacteria…

20 January 2021 - Aptorum Group Ltd

Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)

As part of Aptorum Group’s Acticule infectious disease platform, ALS-4 is a novel orally administered first-in-class small molecule that was…

page 1/27

Events

20 April 2021

Anti-Infectives Drug Development – Digital Event

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been…

22 March 2021

BIO-Europe Spring® Digital — 15th International Partnering Conference

The fifteenth annual BIO-Europe Spring® conference is the premier springtime partnering conference for the life science industry. For its 2021…

04 March 2021

GARDP: Learning from COVID-19 to tackle the silent pandemic of antibiotic resistance

This webinar will focus on how we can apply the lessons learned from COVID-19 to tackle drug resistance and ensure…

25 February 2021

REVIVE Webinar: From discovery to the pre-clinical antimicrobial candidate

REVIVE is a space for everybody with an interest in antimicrobial R&D. The Global Antibiotic Research and Development Partnership (GARDP)…

14 January 2021

REVIVE Webinar: Manipulating the host response to treat infections

Presentations: 1.) Immune modulation and host directed therapies as an adjunctive approach to treating infections (R.E.W. (Bob) Hancock): - Host…

11 January 2021

Biotech Showcase™ Digital 2021

Biotech Showcase™ Digital is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an…

20 November 2020

REVIVE Webinar: Saving childrens’ lives – treating neonatal sepsis

The webinar, organized in collaboration with WHO, is being held on the occasion of Universal Children’s Day and during World…

19 November 2020

XIV European Patients’ Rights Day 2020 – Towards an AMR citizens’ alliance

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

18 November 2020

XIV European Patients’ Rights Day 2020 – Public and private sector challenges to address the “the Silent Tsunami”

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

page 1/9